{"entity":{"type":"insider","cik":"0001762451","url":"/insider/0001762451","json_url":"/insider/0001762451.json","name":"Sinclair Andrew","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":7,"first":"2018-12-27","last":"2022-03-31","span_basis":"filed_date"},"name_variants":[{"name":"Sinclair Andrew","source":"filing","n_filings":7,"first_seen":"2018-12-27","last_seen":"2022-03-31"}],"transactions":[{"id":6674304,"accession":"0000905718-22-000521","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-22-000521","line_url":"/filing/0000905718-22-000521#line-1","is_derivative":false,"issuer_cik":"0001484565","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001484565","owner_cik":"0001762451","owner_name":"Sinclair Andrew","owner_url":"/insider/0001762451","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7720000.0,"shares_display":"7,720,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":18022602.0,"shares_owned_after_display":"18,022,602","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-29","filed_date":"2022-03-31","scope":"insider"},{"id":6118439,"accession":"0000905718-22-000178","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-22-000178","line_url":"/filing/0000905718-22-000178#line-2","is_derivative":false,"issuer_cik":"0001290149","issuer_name":"Sierra Oncology, Inc.","issuer_ticker":"SRRA","issuer_name_source":null,"issuer_url":"/issuer/0001290149","owner_cik":"0001762451","owner_name":"Sinclair Andrew","owner_url":"/insider/0001762451","role":"Director","officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":4050000.0,"total_display":"4,050,000.00","shares_owned_after":1314127.0,"shares_owned_after_display":"1,314,127","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-31","filed_date":"2022-02-01","scope":"insider"},{"id":9206417,"accession":"0000905718-21-001591","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-21-001591","line_url":"/filing/0000905718-21-001591#line-1","is_derivative":false,"issuer_cik":"0001720580","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001720580","owner_cik":"0001762451","owner_name":"Sinclair Andrew","owner_url":"/insider/0001762451","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":7000000.0,"total_display":"7,000,000.00","shares_owned_after":2115385.0,"shares_owned_after_display":"2,115,385","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-08","filed_date":"2021-12-13","scope":"insider"},{"id":4605909,"accession":"0000905718-21-001587","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-21-001587","line_url":"/filing/0000905718-21-001587#line-1","is_derivative":false,"issuer_cik":"0001720580","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001720580","owner_cik":"0001762451","owner_name":"Sinclair Andrew","owner_url":"/insider/0001762451","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":7000000.0,"total_display":"7,000,000.00","shares_owned_after":2140721.0,"shares_owned_after_display":"2,140,721","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-08","filed_date":"2021-12-10","scope":"insider"},{"id":2954312,"accession":"0000905718-20-000724","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-20-000724","line_url":"/filing/0000905718-20-000724#line-1","is_derivative":false,"issuer_cik":"0001484565","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001484565","owner_cik":"0001762451","owner_name":"Sinclair Andrew","owner_url":"/insider/0001762451","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3333330.0,"shares_display":"3,333,330","price_per_share":1.65,"price_display":"1.65","price_state":"stated","total_value":5499994.5,"total_display":"5,499,994.50","shares_owned_after":10302602.0,"shares_owned_after_display":"10,302,602","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-26","filed_date":"2020-07-06","scope":"insider"},{"id":8665428,"accession":"0000905718-19-000875","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-19-000875","line_url":"/filing/0000905718-19-000875#line-1","is_derivative":false,"issuer_cik":"0001484565","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001484565","owner_cik":"0001762451","owner_name":"Sinclair Andrew","owner_url":"/insider/0001762451","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2300000.0,"shares_display":"2,300,000","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":2760000.0,"total_display":"2,760,000.00","shares_owned_after":6969272.0,"shares_owned_after_display":"6,969,272","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-25","filed_date":"2019-10-29","scope":"insider"},{"id":6514659,"accession":"0000905718-18-000995","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-18-000995","line_url":"/filing/0000905718-18-000995#line-1","is_derivative":false,"issuer_cik":"0001484565","issuer_name":"SOLENO THERAPEUTICS INC","issuer_ticker":"SLNO","issuer_name_source":null,"issuer_url":"/issuer/0001484565","owner_cik":"0001762451","owner_name":"Sinclair Andrew","owner_url":"/insider/0001762451","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4669272.0,"shares_display":"4,669,272","price_per_share":1.6,"price_display":"1.60","price_state":"stated","total_value":7470835.2,"total_display":"7,470,835.20","shares_owned_after":4669272.0,"shares_owned_after_display":"4,669,272","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-21","filed_date":"2018-12-27","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001484565","name":"SOLENO THERAPEUTICS INC","url":"/issuer/0001484565","role":"Director","n_filings":4,"first_seen":"2018-12-27","last_seen":"2022-03-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001290149","name":"Sierra Oncology, Inc.","url":"/issuer/0001290149","role":"Director","n_filings":1,"first_seen":"2022-02-01","last_seen":"2022-02-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001720580","name":"Adicet Bio, Inc.","url":"/issuer/0001720580","role":"Director","n_filings":2,"first_seen":"2021-12-10","last_seen":"2021-12-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001762451","retrieved_at":"2026-08-21T10:19:58+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}